Systems for the intrapulmonary delivery of aerosolized aqueous formulations
First Claim
1. A disposable package, comprising:
- a container having at least one wall which is collapsible by the application of a force the container having therein a dry pharmaceutically active drug with at least one wall having an opening;
a porous membrane covering the opening wherein the membrane pores have a diameter in the range of from about 0.25 micron to about 6 microns; and
a liquid container having a flowable liquid therein, the liquid container being in fluid connection with the container having the dry drug therein, wherein the liquid container is separated from the container having the dry drug therein by a membrane which is ruptured upon the application of force.
2 Assignments
0 Petitions
Accused Products
Abstract
A disposable package, tape, and cassette are provided which makes it possible to hold and disperse therefrom liquid, flowable formulations including aqueous formulations (solutions or dispersions with particles less than 0.25 microns in diameter) of a pharmaceutically active drug. In one embodiment formulation is packaged in individual dosage unit containers which containers are preferably interconnected. The package is designed to be integrated into a cassette which can be loaded into a dispersing device capable of individually opening dosage unit containers and aerosolizing the contents through a porous membrane, into a mouth piece on the cassette, for delivery to a patient. In addition to and alongside of each porous membrane, the package may include one or more openings through which air is forced in order to aid in avoiding the accumulation of aerosolized particles. The package may be configured so that the formulation is held in a container not positioned directly vertical to and below the porous membrane, thus making it necessary to channel formulation horizontally to the porous membrane and making it possible to include a vibrating mechanism directly below a chamber covered by the porous membrane. Release of aerosolized drug is breath actuated based on simultaneous measurements of inspiratory flow and volume so as to provide for repeatable dosing of drug to the patient.
363 Citations
17 Claims
-
1. A disposable package, comprising:
-
a container having at least one wall which is collapsible by the application of a force the container having therein a dry pharmaceutically active drug with at least one wall having an opening; a porous membrane covering the opening wherein the membrane pores have a diameter in the range of from about 0.25 micron to about 6 microns; and a liquid container having a flowable liquid therein, the liquid container being in fluid connection with the container having the dry drug therein, wherein the liquid container is separated from the container having the dry drug therein by a membrane which is ruptured upon the application of force. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8)
-
-
9. A disposable package, comprising:
-
a container having an opening leading to a channel, the container having a liquid, flowable formulation therein which formulation comprises a pharmaceutically active drug, wherein at least one wall of the container is collapsible in a manner so as to allow the formulation in the container to be forced out of the opening into the channel; a resonance cavity in fluid connection with the container by means of the channel, the resonance cavity having a porous membrane wherein pores of the membrane have a diameter in the range of 0.25 to 6 microns. - View Dependent Claims (10, 11, 12, 13, 14)
-
-
15. A disposable drug delivery cassette for use in aerosolized delivery of drugs to lungs, comprising:
-
an outer protective cover having positioned therein; a disposable package comprised of a plurality of interconnected individual disposable drug containers, with each container having an opening which opening leads to an open channel which includes an abutment which is broken on the application of force and an area beyond the abutment which is covered by a disposable porous membrane having pores with a diameter of about 0.25 to 6 microns, with each container containing a liquid formulation comprising a pharmaceutically active drug; wherein the formulation has a viscosity of which is sufficiently low such that the formulation is aerosolized to particles having a diameter of about 0.5 to 12 microns when moved out of the pores. - View Dependent Claims (16, 17)
-
Specification